
Azawan Tablet
Marketer
Rowan Bioceuticals Pvt Ltd
Salt Composition
Azathioprine (50mg)
Overview Azawan Tablet
Immunosuppressant medication, Azawan Tablet, is prescribed post-transplant (kidney, heart, liver, etc.) alongside other drugs to prevent organ rejection. It's also indicated for rheumatoid arthritis. Its mechanism involves immune system modulation, preventing the body from attacking the transplanted organ. Dosage and frequency are transplant-specific; strictly adhere to your physician's instructions. Ingestion with food is recommended. Consistent use is crucial for efficacy; discontinuation elevates the risk of transplant rejection. Potential adverse effects include nausea, appetite suppression, and heightened bleeding risk. Immunosuppression increases infection susceptibility and cancer risk. Report any concerning side effects immediately. Azawan Tablet is contraindicated during pregnancy, lactation, or pregnancy planning due to teratogenic and abortifacient potential. Consult your doctor before use if you experience infections, unusual bleeding or bruising, or are taking other medications, as interactions are possible. Regular blood tests will monitor your blood cell counts.
Primary Ingredients of Azawan Tablet
No text provided to rephrase.
Uses of Azawan Tablet
Immunosuppression for transplant recipients and management of rheumatoid arthritis.
Major Benefits of Azawan Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Azawan Tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with food.
Common Side effects of Azawan Tablet:
- Decreased white blood cell count
- Increased bleeding tendency
- Nausea
- Infection
- Loss of appetite
How to use Azawan Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Azawan Tablet whole; do not crush, chew, or divide it. Administer this medication with food.
How Azawan Tablet works:
Immunosuppressant Azawan Tablet diminishes the body's immune response, thereby mitigating organ transplant rejection. Furthermore, it inhibits inflammatory chemical mediators, alleviating swelling, redness, and inflammation characteristic of some arthritic conditions.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Azawan Tablet lacks established safety data. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Use of Azawan Tablet is contraindicated during pregnancy due to established risks to fetal development. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Always seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Use of Azawan Tablet while breastfeeding is likely inadvisable. Scant evidence in humans indicates potential drug transfer to breast milk, posing a possible risk to the infant.
DrivingCONSULT YOUR DOCTOR
Azawan Tablet's effect on driving ability is unknown. Refrain from driving if symptoms impairing concentration or reaction time occur.
KidneyCAUTION
Individuals with impaired kidney function should exercise caution when using Azawan Tablets, potentially requiring a modified dosage. Medical advice is recommended. Azawan Tablets are contraindicated for patients with severe kidney disease.
LiverCAUTION
Individuals with liver impairment should use Azawan Tablets cautiously, potentially requiring dosage modification. Consult a physician before use. Azawan Tablets are contraindicated in patients with severe hepatic dysfunction. Consistent monitoring of liver function is recommended during treatment.
What if you forget to take Azawan Tablet :
Should you forget a dose of Azawan Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Azawan Tablet
| Label | Value |
|---|---|
| Chemical Category | Nucleoside Analogs and Purines |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Action Class | Purine analog immunosuppressants |
